Archive for April 2017

CTD Holdings Clinical Trial

CTD Holding’s Trappsol Cyclodextrin trial is currently enrolling in two trial sites: Oakland, US and Manchester, UK.  The Phase 1 trial in the US requires patients to be 18+ and is looking to recruit approximately 12 patients for a research study lasting up to 20 weeks.   The Phase 1/2 trial in the UK is also looking…

Read More

Orphazyme trial update

Orphazyme recently announced that its interventional trial of Arimoclomal has achieved its recruitment target. The company has recruited 46 NPC patients in 8 countries for this 12 month placebo-controlled trial. There are two centres in the UK; Great Ormand Street and Birmingham. William has been on the trial now for about 6 weeks (patients do not know…

Read More